Posted by AGORACOM-JC
at 8:45 AM on Thursday, September 3rd, 2020
The global online gambling market could potentially hit $1 TRILLION by the end of this decade. That isn’t a typo and the reasons are pretty clear – more jurisdictions are legalizing online gambling to get their hands on the tax revenue and the remaining 40% of people on the planet without internet access are going to get it.
Until recently, however, small-cap investors did not have a company that could provide them ground floor exposure to this massive market and its growth over the next 10 years. The industry was dominated by the big traditional gambling companies, who focus heavily on old fashioned gambling.
That all changes with FansUnite, the small cap iGaming super company that goes beyond simple gambling and attacks both sides of the iGaming market by offering both B2C and B2B gambling platforms.
$5,000,000 Financing In Support Of The Acquisition
World Renowned Team
…. And now FANS just entered the US market in record time thanks to a partnership that saved them 12-24 months and millions and millions of dollars.
If you are looking for a disruptive technology company that is well positioned to carve out its share of the massive online gambling world, then you need to watch or listen to our interview with FANS CEO, Scott Burton.
Posted by AGORACOM-JC
at 8:22 AM on Thursday, September 3rd, 2020
Kontrol BioCloud a Safe Space Technology™
During the week of August 31, 2020 Kontrol continued lab testing on its fully operating prototype to validate certain components required for commercialization of BioCloud
The testing continues to demonstrate positive results as previously reported in the press release dated August 27, 2020.
live COVID-19 testing has been rescheduled to the week of September 8th in order to secure ample time slots in the independent lab
To align with the completion of COVID-19 live testing, Kontrol anticipates having 5 functioning BioCloud units that can operate in real-time in the coming weeks
TORONTO, ON / September 3, 2020 / Kontrol Energy Corp.(CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to provide an update on its Kontrol BioCloud (or “BioCloud“) technology.
Lab Testing with Prototype and Dormant COVID
During the week of August 31, 2020 Kontrol continued lab testing on its fully operating prototype to validate certain components required for commercialization of BioCloud. The testing continues to demonstrate positive results as previously reported in the press release dated August 27, 2020.
“Through additional testing we are in a position where we can determine that our detection chamber and fully operational prototype continue to deliver positive results against COVID-19 in its dormant form,” says Paul Ghezzi, CEO Kontrol. “In addition, we have enhanced supply chain certainty over all material components required for commercialization.”
Live COVID-19 Testing
The live COVID-19 testing has been rescheduled to the week of September 8th in order to secure ample time slots in the independent lab.
Prototypes and Function Units
To align with the completion of COVID-19 live testing, Kontrol anticipates having 5 functioning BioCloud units that can operate in real-time in the coming weeks.
About Kontrol BioCloud
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.
About Kontrol Energy
Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.
Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.
For further information, contact:
Paul Ghezzi, Chief Executive Officer [email protected] or [email protected] Kontrol Energy Corp., 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
Posted by AGORACOM
at 8:17 AM on Thursday, September 3rd, 2020
TORONTO, ON /September 3, 2020 / Gratomic Inc. (“GRAT” or the “Company”) (TSXV:GRAT) (OTC: CBULF) (FRANKFURT:CB81) (WKN:A143MR) aims to become a cleaner graphite source for North American consumers and is pleased to announce the Company’s objective to process graphite in a clean and environmentally responsible manner.
As the battery manufacturing industry becomes increasingly competitive, many electric vehicle battery manufacturers are currently forced towards choosing lesser environmentally friendly graphite options. In many cases, the mining and processing methods used can be unsafe and some have the potential to cause major pollution in neighbouring cities and towns. Alternatively, many electric vehicle battery manufacturers are turning to synthetic graphite sources, often created in labs from petroleum and biogas by-products, among other carbon sources. These methods can also potentially produce undesirable emissions during the processing phase.
Arno Brand: President and CEO commented:
As the world is becoming more drawn towards Cleaner metals, Gratomic is taking on a leadership position by aiming to produce higher quality Cg with a lower carbon footprint. We have a clear objective as a company, to maximize engineering efforts and to minimize environmental impact. We intend to create a new commodity class that includes, as part of the product specifications, the environmental footprint imposed by producing that tonne of material in an effort to provide buyers with full disclosure on the product’s impact.
In its design efforts, the Gratomic team has taken every possible step to minimize environmental impact and lower the carbon footprint of Gratomic graphite. The Company has designed new and innovative graphite processing procedures that will produce higher quality graphite while minimizing environmental impacts and lowering the carbon footprint created during the processing phase. Calculations conducted internally by our team of industry experts reveals that the production of one tonne of graphite at a percentage of approximately 98% Cg will create a very low carbon footprint of 0.8Kg of carbon emissions, or 16,000 kg per annum.
We believe accomplishing this objective is a positive environmental step forward and a true example of Gratomic’s vision, innovation, and leadership in the graphite mining industry. Our graphite processing design also encompasses a unique water recycling and filtration system that is expected to recover up to 95% of the water used during the processing phase.
The graphite intended for processing at the Company’s Aukam Graphite Project is in a naturally weathered state and contains little deleterious elements mitigating any lasting negative environmental impacts. This information has been verified through numerous analytical results from testing programs. Pilot testing has validated that the majority of the reject material contained minor amounts of clay silica and iron with smaller traces of calcium. The rejects material when analyzed did not contain any sulfur or heavy metals which generally pose the greatest environmental threat.
The Company utilizes all resources so efficiently and effectively that waste is extremely limited. Gratomic is highly focused on recycling and has found a use for the residual material that resides in its tailing ponds. This slurry by-product to be extracted from the tailing ponds is intended to be recycled into bricks. It would be combined with concrete and compressed, and the residual graphite contained in the slurry, when incorporated into the bricks, should result in stronger, longer lasting product, particularly in hot climates.
Gratomic wishes to emphasize that no Preliminary Economic Analysis (“PEA”), Preliminary Feasibility Study or Feasibility Study has been completed to support any level of production. In fact, no mineral resources, let alone mineral reserves demonstrating economic viability and technical feasibility, have been delineated on the Aukam Property.
The Company recently appointed Dr. Ian Flint to complete a preliminary economic assessment (PEA) on the Aukam Processing plant. The study, its recommendations, and their subsequent implementation, will provide conclusions and recommendation at a PEA level of comfort relating to the scale up of the existing processing plant to a commercial scale processing facility that will provide the desired concentrate grades and production rates.
A preliminary economic assessment is preliminary in nature, it includes inferred mineral resources that are considered too speculative geologically to have economic considerations applied to them that would enable them to be categorized as mineral reserves, and there is no certainty that the preliminary economic assessment will be realized.
Gratomic wishes to emphasize that the supply of graphite pursuant to any off-take or supply agreement referred to in this Press Release is conditional on Gratomic being able to bring the Aukam project into a production phase, and for any graphite being produced to meet certain technical and mineralization requirements. Gratomic continues to move its business towards production and as part of its business plan, expects to obtain a National Instrument 43-101 Standards of Disclosure for Mineral Projects technical report to help it ascertain the economics of the Aukam project. Risk Factors
No mineral resources, let alone mineral reserves demonstrating economic viability and technical feasibility, have been delineated on the Aukam Property. The Company is not in a position to demonstrate or disclose any capital and/or operating costs that may be associated with the processing plant.
The Company advises that it has not based its production decision on even the existence of mineral resources let alone on a feasibility study of mineral reserves, demonstrating economic and technical viability, and, as a result, there may be an increased uncertainty of achieving any particular level of recovery of minerals or the cost of such recovery, including increased risks associated with developing a commercially mineable deposit. Historically, such projects have a much higher risk of economic and technical failure. There is no guarantee that production will begin as anticipated or at all or that anticipated production costs will be achieved.
Failure to commence production would have a material adverse impact on the Company’s ability to generate revenue and cash flow to fund operations. Failure to achieve the anticipated production costs would have a material adverse impact on the Company’s cash flow and future profitability Steve Gray, P. Geo. and a Director of the Company has reviewed and approved the scientific and technical information in this press release and is the Company’s “Qualified Person” as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects.
About Gratomic Inc.
Gratomic is an advanced materials company focused on mine to market commercialization of graphite products and components for a range of mass market products. The Company currently holds two off-take purchase agreements for graphite product sourced from the Aukam facility. One agreement is with TODAQ and the other is with Phu Sumika. The Company is listed on the TSX Venture Exchange under the symbol GRAT. For more information: visit the website at www.gratomic.ca or contact: Arno Brand at [email protected] or 416 561-4095 “Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.”
Posted by AGORACOM-JC
at 7:17 AM on Thursday, September 3rd, 2020
Mackie Research’s analyst, Yue (Toby) Ma, Ph.D., indicates in the updated Enterprise report that Innocan’s potential catalysts are:
Clinical Catalyst: Pre-clinical data of CLX in COVID-19 is expected in 9 to 12 months.
Licensing Catalyst: Innocan is looking to out-license CLX and the liposome product before Phase 1 trials.
Commercial Catalyst: Innocan’s CBD-based consumer health products are expected to be launched in several international markets in Q4 2020. The company is looking to sign more regional distribution agreements going forward.
Herzliya, Israel and Calgary, Alberta–(September 3, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to announce that Mackie Research Capital Corporation’s institutional sales group has issued an updated Enterprise report on the Company.
The Enterprise report provides valuable insight into companies that embody value-add for investors, have distinguished themselves among their peers and are bringing innovative and creative ideas into action.
Mackie Research’s analyst, Yue (Toby) Ma, Ph.D., indicates in the updated Enterprise report that Innocan’s potential catalysts are:
Clinical Catalyst: Pre-clinical data of CLX in COVID-19 is expected in 9 to 12 months.
Licensing Catalyst: Innocan is looking to out-license CLX and the liposome product before Phase 1 trials.
Commercial Catalyst: Innocan’s CBD-based consumer health products are expected to be launched in several international markets in Q4 2020. The company is looking to sign more regional distribution agreements going forward.
This Enterprise report is based upon general comments with no ratings and should not be construed to be a research report.
About Innocan
The Company, through its wholly owned subsidiary, Innocan Pharma Ltd., is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”). Innocan and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD. CBD-Loaded Exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.
The Company signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release Liposome to be administrated by Injection. The Company plans, together with Prof. Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University to test the Liposome platform on several potential indications. The Company is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of InnoCan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.
For further information, please contact:
For Innocan Pharma Corporation: Iris Bincovich, CEO +972-54-3012842 [email protected]
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Caution regarding forward-looking information
Certain information set forth in this news release is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond InnoCan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by InnoCan, including expectations and assumptions concerning the anticipated benefits of the product, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements. Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact InnoCan can also be found in InnoCan’s public reports and filings which are available under InnoCan’s profile at www.sedar.com.
Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. InnoCan Pharma does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law. Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.
Posted by AGORACOM-JC
at 11:11 AM on Wednesday, September 2nd, 2020
SPONSOR: Esports Entertainment Group(GMBL:NASDAQ) Millions of people from around the world tune in to watch teams of video game players compete with each other. In first quarter 2020, YouTube reported 1.1 billion hours watched, an increase of 13% when compared to fourth quarter 2019. Wagering on Esports is projected to hit $23 BILLION this year although that number will likely be eclipsed due to the recent pandemic. Esports Entertainment Group is designed for the purpose of facilitating as much of this wagering as possible. LEARN MORE.
DraftKings surges 12% after Michael Jordan takes equity stake and special adviser role
DraftKings surged as much as 12% on Wednesday after basketball legend Michael Jordan took an equity interest in the firm.
Jordan’s stake comes in exchange for “providing guidance and strategic advice” to the sports betting company, according to a press release.
The six-time NBA champion will advise DraftKings on a variety of topics including company strategy, development, diversity, equity, and marketing.
DraftKings shares rocketed as much as 12% on Wednesday after announcing basketball superstar Michael Jordan took an equity stake in the company.
The six-time National Basketball Association champion took an equity interest in exchange for “providing guidance and strategic advice” to DraftKings’ board of directors, according to a Wednesday press release. The sports betting company plans to tap Jordan for input on company strategy, development, diversity, equity, and marketing activities.
“The strategic counsel and business acumen Michael brings to our board is invaluable, and I am excited to have him join our team,” CEO and co-founder Jason Robins said in the release.
Jordan’s role as a special advisor to DraftKing’s board of directors is effective immediately, the company said.
DraftKings began trading publicly in April after merging with special-purpose acquisition company Diamond Eagle. Shares have since rallied as investors position for sports gambling to pick up as major leagues resume activity.
The exposure to major sports in the middle of the coronavirus pandemic cuts both ways. While the start of the NBA and Major League Baseball seasons boosted shares, the stock tumbled as much as 13% on July 27 when a COVID outbreak halted several MLB games.
DraftKings closed at $36.93 per share on Tuesday, up 247% year-to-date.
Posted by AGORACOM-JC
at 11:04 AM on Wednesday, September 2nd, 2020
Hilaria Baldwin Chooses Else Nutrition on E! Daily Pop
https://youtu.be/UBiYSt9Jekg
“As many of you know, my family primarily eats a dairy-free, plant-based diet. I nurse my babies and am always looking for a plant-based toddler formula to transition to once they are weaned. There hasn’t been anything on the market except soy until now. This is why I’m so excited to share @elsenutrition with you – it’s the first clean-label, plant-based formula for toddlers. Romeo and I are making their Complete Nutrition Drink which helps support his growth and development during this key time. Else is organic and non-GMO. It’s FDA-compliant, dairy, soy, and hormone-free. There are no antibiotics, palm oil, or corn syrups that are traditionally found in infant and toddler formulas and milks, so your babies can get the nutrition nature intended! I highly recommend this amazing alternative, especially if you’re like me where you’ve been looking for something Else!”
Posted by AGORACOM
at 10:09 AM on Wednesday, September 2nd, 2020
Shares are now quoted on the Frankfurt Stock Exchange under the trading symbol LO51.
TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) reports that its common shares are now quoted on the Frankfurt Stock Exchange under the trading symbol LO51.
John Barker, VP of Business Development, commented: “Loncor has dramatically developed over the last 12 months with the Company growing through increased gold resources, ongoing exploration and the commencement of drilling by our JV partner, Barrick Gold. The listing on the Frankfurt Stock Exchange will heighten Loncor’s exposure in this major marketplace, given its knowledgeable investor base that is traditionally very active in the junior resource sector. As the interest in gold and gold investments heightens, having its common shares quoted in Euros will assist European investors to participate in Loncor’s growth.”
About Loncor Resources Inc. Loncor is a Canadian gold exploration company focussed on the Ngayu Greenstone Belt in the northeast of the Democratic Republic of the Congo (the “DRC”). The Loncor team has over two decades of experience of operating in the DRC. Ngayu has numerous positive indicators based on the geology, artisanal activity, encouraging drill results and an existing gold resource base. The area is 220 kilometres southwest of the Kibali gold mine, which is operated by Barrick Gold (TSX: “ABX”; NYSE: “GOLD”). In 2019, Kibali produced record gold production of 814,000 ounces at “all-in sustaining costs” of US$693/oz. Barrick has highlighted the Ngayu Greenstone Belt as an area of particular exploration interest and is moving towards earning 65% of any discovery in 1,894 km2 of Loncor ground that they are exploring. As per the joint venture agreement signed in January 2016, Barrick manages and funds exploration on the said ground until the completion of a pre-feasibility study on any gold discovery meeting the investment criteria of Barrick. In a recent announcement Barrick highlighted six prospective drill targets and have commenced confirmation drilling in 2020. Subject to the DRC’s free carried interest requirements, Barrick would earn 65% of any discovery with Loncor holding the balance of 35%. Loncor will be required, from that point forward, to fund its pro-rata share in respect of the discovery in order to maintain its 35% interest or be diluted.
In addition to the Barrick JV, certain parcels of land within the Ngayu Belt surrounding and including the Adumbi and Makapela deposits have been retained by Loncor and do not form part of the joint venture with Barrick. Barrick has certain pre-emptive rights over the Makapela deposit. Adumbi and two neighbouring deposits hold an inferred mineral resource of 2.5 million ounces of gold (30.65 million tonnes grading 2.54 g/t Au), with 76.29% of this resource being attributable to Loncor via its 76.29% interest in the project. Loncor’s Makapela deposit (which is 100%-owned by Loncor) has an indicated mineral resource of 614,200 ounces of gold (2.20 million tonnes grading 8.66 g/t Au) and an inferred mineral resource of 549,600 ounces of gold (3.22 million tonnes grading 5.30 g/t Au).
Resolute Mining Limited (ASX/LSE: “RSG”) owns 26% of the outstanding shares of Loncor and holds a pre-emptive right to maintain its pro rata equity ownership interest in Loncor following the completion by Loncor of any proposed equity offering.
Additional information with respect to Loncor and its projects can be found on Loncor’s website at www.loncor.com.
Qualified Person Peter N. Cowley, who is President of Loncor and a “qualified person” as such term is defined in National Instrument 43-101, has reviewed and approved the technical information in this press release.
Posted by AGORACOM
at 9:11 AM on Wednesday, September 2nd, 2020
Toronto, Ontario–(Newsfile Corp. – September 2, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has solidified its arrangement with McSmart (as defined by the listing statement) for the launch of its previously announced Microdosing Packs through three Smart Shops operated by McSmart. The Microdosing Packs are anticipated to become available for purchase to consumers in the Netherlands before the end of September 2020, at the following Smart Shop locations: (i) two Tatanka locations, and (ii) the Headshop. In addition, the Microdosing Packs are also expected to become available for purchase in the Netherlands on Tatanka’s website at www.tatanka.nl.
“All of us at Red Light Holland are very excited as our Microdosing Packs are so close to being on shelves and available for online purchases. We are still anticipating our premiere product launch, with our newly coined phrase “iMicrodose,” happening later this month, and working so closely with McSmart is something we are truly appreciative of,” said Todd Shapiro, Chief Executive Officer and Director of the Company.
Magic truffles, which are sold in their natural, raw and unprocessed form, need to be refrigerated. As such, two of the Smart Shops are also expected to feature Red Light Holland-branded fridges to house the magic truffles and display their iMicrodose packs in a clever and unique way. The Microdosing Packs have a shelf-life of approximately 3 months. Red Light Holland Microdosing Packs
About Red Light Holland Corp.
The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws. The Company’s brand of magic truffles are expected to be sold in the Netherlands through existing Smart Shops as well as its e-commerce platform, and are expected to be initially made available in the form of its previously announced Microdosing Packs.
For additional information on the Company:
Todd Shapiro Chief Executive Officer and Director Tel: 647-204-7129
Posted by AGORACOM-JC
at 6:58 AM on Wednesday, September 2nd, 2020
Wholly owned subsidiary Askott Entertainment has signed a partnership agreement with Las Vegas based GameCo LLC, a pioneer in skill based iGaming products
The partnership will introduce Askott Entertainments esports iGaming platform, Chameleon, to the US regulated market
GameCo holds gaming licenses in almost thirty jurisdictions including, New Jersey and Nevada in the United States
Askott Entertainment will leverage this US license infrastructure by enabling GameCo to become an official reseller of the Chameleon esports betting platform to new and existing partners which will include U.S based casino operators
The partnership agreement will give the combined group an early mover advantage in the U.S. esports iGaming market
Vancouver, British Columbia–(September 2, 2020) – FansUnite Entertainment Inc. (CSE: FANS) (OTC Pink: FUNFF) (“FansUnite” or the “Company”), a technology company providing leading online gaming solutions, is pleased to announce that its wholly owned subsidiary Askott Entertainment has signed a partnership agreement with Las Vegas based GameCo LLC, a pioneer in skill based iGaming products (“GameCo”). The partnership will introduce Askott Entertainments esports iGaming platform, Chameleon, to the US regulated market.
GameCo holds gaming licenses in almost thirty jurisdictions including, New Jersey and Nevada in the United States. Askott Entertainment will leverage this US license infrastructure by enabling GameCo to become an official reseller of the Chameleon esports betting platform to new and existing partners which will include U.S based casino operators. The partnership agreement will give the combined group an early mover advantage in the U.S. esports iGaming market. As the U.S. is one the most desirable and active gambling markets globally, having a presence in that jurisdiction is an integral part of the FansUnite strategy.
“With this newly launched partnership, we are able to showcase our turn-key white label iGaming solution while officially launching our technology into the burgeoning U.S. gaming market,” said Scott Burton, CEO of FansUnite Entertainment. “We are aware of the sizable market that the U.S. presents, and understand that esports is a key component to any traditional sportsbooks future betting offering. This partnership with GameCo is a significant inflection point for FansUnite and accelerates our plans to enter the US market by at least 6-12 months.”
“GameCo was born from the founders’ involvement in the esports industry and invented the category of skill-based Video Game Gambling™. We intend to carry our market leadership position in the U.S. regulated market and provide the industry’s leading turkey, outsourced solution for casinos and sportsbooks to offer esports betting,” said Blaine Graboyes, Co-Founder and CEO of GameCo. “Skill-based games and esports betting are one of the few growth opportunities in the U.S. and we believe Askott provides the most capable and innovative platform for offering iGaming and esports betting.”
With the repeal of PASPA in 2018 any state is now allowed to legalize sports betting. Since that time more than $20 billion has been bet with U.S. sportsbooks1.
About GameCo
GameCo LLC is the foremost innovator and trailblazer in creating new, differentiated gaming products and experiences which are driving the growth in the digital and retail regulated casino industries. The inventor of the world’s first skill-based Video Game Gambling Machine (VGM™), GameCo’s omnichannel land-based and online platform combines the fun and interactivity of video games with the thrill and anticipation of gambling. The company’s patent-pending GamersEdge™ technology allows a player’s skill and strategy to impact the payout and winnings, while maintaining similar economics for the casino as traditional slots. Through its Video Game Gambling™ platform and gaming licenses in dozens of jurisdictions, GameCo enables game developers and publishers to distribute and monetize video games into the licensed gaming market and enables operators to attract and engage new, different customers. GameCo offers a wide portfolio of casino, sports, and core game genres in both single player and esports-style multiplayer formats for retail casinos, and through the iGameCo brand, for digital casinos with iGaming, and esports betting.
GameCo LLC is privately held and headquartered in Las Vegas with additional offices in New York City. GameCo is currently licensed to operate in more than twenty gaming jurisdictions, including Nevada.
About FansUnite Entertainment Inc.
FansUnite is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and other related products. FansUnite has produced a one of a kind complete iGaming platform, Chameleon Gaming Platform, with a sports and esports focus geared for the next generation of online bettors and casino players. The platform includes products for pre-match betting, in-play betting, daily fantasy, content and a certified RNG to produce casino style chance games. The platform operates multiple B2C brands and B2B software for the online gambling industry. FansUnite also looks to acquire technology platforms and assets with high-growth potential in new or developing markets.
For further information, please contact:
Prit Singh Investor Relations at FansUnite [email protected] (905) 510-7636
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute “forward-looking information” under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “believes,” “belief,” “expects,” “intends,” “anticipates,” “potential,” “should,” “may,” “will,” “plans,” “continue” or similar expressions to be uncertain and forward-looking. Forward-looking statements may include, without limitation, statements relating to future outlook and anticipated events such as: the leveraging of GameCo’s US license infrastructure; GameCo becoming an official reseller of the platform; the Company’s entrance into the US market and the Company’s strategy with respect thereto; the importance of the US market to the Company; impacts of the GameCo/Askott partnership on the Company’s success; the Company’s ability to become a leading technology platform and a leader in the global I-gaming market, and to serve the gaming market; the potential growth of the Company and the gaming market; the increased number of betting options; the ability of the Company to scale its B2B arm and maintain its B2C platforms; the Company’s unique portfolio of assets; and discussion of future plans, projections, objectives, estimates and forecasts and the timing related thereto. Forward-looking statements are based on the Company’s estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of FansUnite to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Additional information regarding the risks and uncertainties relating to the Company’s business are contained under the heading “Risk Factors” in the Company’s Non-Offering Prospectus dated March 27, 2020 filed on its issuer profile on SEDAR at www.sedar.com and risks related to global pandemics, including the novel coronavirus (COVID-19) global health pandemic, and the spread of other viruses or pathogens and influence of macroeconomic developments. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The forward-looking statements in this news release are made as of the date of this release. FansUnite disclaims and does not undertake to update or revise any forward-looking statements or forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.
Posted by AGORACOM-JC
at 6:28 PM on Tuesday, September 1st, 2020
Hollister Biosciences (HOLL:CSE). is a multi-state operator with multiple, high-quality products that are now carried in 230 of California’s 600 dispensaries, where it also claims California’s #1 hash infused pre-roll “HashBone” + another 80 Arizona dispensaries with some of the best concentrate in the State.
But given the state of disappointment in the Cannabis industry over the last 15 months, none of that would mean anything without actual results shareholders and the industry could celebrate. In that regard, Hollister does not disappoint with Q2 numbers coming in as follows:
RECORD REVENUE of $US 8.47M, compared to $200,000 last year and representing an increase of 4,170%
NET INCOME of $300,000, compared to a loss of $2.1M, representing a turnaround of $2.4M over last year
There isn’t a small cap cannabis company that would not cheer for these results – if that was all they had. These numbers are a company maker. But Hollister is set to continue growing on several fronts, including a Direct To Consumer model and further big expansion in California.
Watch this incredible interview with President Alex Somjen.
